Search
for

    Sort by

    Research 721–750 of 1000+

    1. Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil International journal of toxicology · 2001 · 23 citations
    2. Amino Acids Oral Treatment for the Amelioration of Skin, Hair, and Nails Conditions: An Open-Label Study Current research in nutrition and food science · 2024
    3. Long-term treatment within a maximum of 96 weeks of tinea unguium with long-pulsed neodymium-doped yttrium aluminum garnet laser Journal of The American Academy of Dermatology · 2015
    4. Adipose-Derived Stem Cells and Their Secretory Factors for Skin Aging and Hair Loss Springer eBooks · 2015
    5. Gingival Hyperplasia Secondary to Everolimus Therapy Actas Dermo-Sifiliográficas · 2010
    6. Drugs affecting blood coagulation, fibrinolysis, and hemostasis Side effects of drugs annual · 2009
    7. Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin International journal of pharmaceutics · 2011 · 34 citations
    8. Adverse events with finasteride or dutasteride: FAERS Reactions Weekly · 2018
    9. Finasteride: suicidality or psychological adverse events Reactions Weekly · 2020
    10. Risk of muscular adverse effects with finasteride Reactions Weekly · 2017
    11. Case reports suggest a broader range of sexual adverse events in patients receiving finasteride [Propecia, Proscar] than previously reported, Reactions Weekly · 2012
    12. Finasteride- versus dutasteride-related sexual AEs Reactions Weekly · 2026
    13. Finasteride toxicity information: “limited”, “poor quality”, “biased” Reactions Weekly · 2015
    14. Lichenoid red tatoo reaction and alopecia areata International Journal of Dermatology · 2011
    15. HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Elsevier eBooks · 2014 · 2 citations
    16. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options Allergy · 2006 · 130 citations
    17. Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin Dermatology · 2014 · 15 citations
    18. Dermatologic Reactions to Targeted Therapy Nursing Clinics of North America · 2017 · 15 citations
    19. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin Australasian Journal of Dermatology · 2010 · 121 citations
    20. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    21. Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database Frontiers in Pharmacology · 2025 · 3 citations
    22. Hypersensitivity Reactions to Homemade Topical Preparations. PubMed · 2023
    23. Cutaneous reactions to recombinant cytokine therapy Journal of The American Academy of Dermatology · 1995 · 105 citations
    24. Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases British Journal of Dermatology · 2011 · 19 citations
    25. Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010 · 223 citations
    26. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007 · 85 citations
    27. Adverse effects of common medications on male fertility Nature Reviews Urology · 2015 · 77 citations
    28. Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases Frontiers in Pharmacology · 2024 · 25 citations
    29. Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database Frontiers in Pharmacology · 2025 · 2 citations
    30. Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 PLoS ONE · 2025